288 related articles for article (PubMed ID: 32643535)
1. The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Huang Q; Xiong H; Shuai T; Wang Y; Zhang C; Zhang M; Zhu L; Lu J; Liu J
Ther Adv Respir Dis; 2020; 14():1753466620938546. PubMed ID: 32643535
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD.
AboEl-Magd GH; Mabrouk MM
J Bras Pneumol; 2018; 44(1):36-41. PubMed ID: 29538541
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
4. Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
Böcskei RM; Benczúr B; Losonczy G; Illyés M; Cziráki A; Müller V; Bohács A; Bikov A
Lung; 2019 Apr; 197(2):189-197. PubMed ID: 30820636
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
Godtfredsen NS; Jørgensen DV; Marsaa K; Ulrik CS; Andersen O; Eugen-Olsen J; Rasmussen LJH
Respir Res; 2018 May; 19(1):97. PubMed ID: 29783959
[TBL] [Abstract][Full Text] [Related]
7. The role of serum soluble urokinase-type plasminogen activator receptor in stable chronic obstructive pulmonary disease.
Can Ü; Güzelant A; Yerlikaya FH; Yosunkaya Ş
J Investig Med; 2014 Oct; 62(7):938-43. PubMed ID: 25127435
[TBL] [Abstract][Full Text] [Related]
8. The Diagnostic and Prognostic Value of suPAR in Patients with Sepsis: A Systematic Review and Meta-Analysis.
Huang Q; Xiong H; Yan P; Shuai T; Liu J; Zhu L; Lu J; Yang K; Liu J
Shock; 2020 Apr; 53(4):416-425. PubMed ID: 31490358
[TBL] [Abstract][Full Text] [Related]
9. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
[TBL] [Abstract][Full Text] [Related]
10. Association between tumor necrosis factor-α and chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Yao Y; Zhou J; Diao X; Wang S
Ther Adv Respir Dis; 2019; 13():1753466619866096. PubMed ID: 31390957
[TBL] [Abstract][Full Text] [Related]
11. NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.
Su X; Lei T; Yu H; Zhang L; Feng Z; Shuai T; Guo H; Liu J
Int J Chron Obstruct Pulmon Dis; 2023; 18():811-825. PubMed ID: 37197601
[TBL] [Abstract][Full Text] [Related]
12. Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis.
Ni W; Han Y; Zhao J; Cui J; Wang K; Wang R; Liu Y
Sci Rep; 2016 Dec; 6():39481. PubMed ID: 27991579
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis.
Shuai T; Pei Jing Y; Huang Q; Xiong H; Liu J; Zhu L; Yang K; Jian L
BMJ Open; 2019 Oct; 9(10):e031812. PubMed ID: 31594897
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
15. Association between Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Shuai T; Yan P; Xiong H; Huang Q; Zhu L; Yang K; Liu J
Biomed Res Int; 2019; 2019():6927456. PubMed ID: 31886242
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome.
Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P
Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350
[TBL] [Abstract][Full Text] [Related]
17. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F
Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
19. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.
Sörensen NA; Nikorowitsch J; Neumann JT; Rübsamen N; Goßling A; Hartikainen TS; Blankenberg S; Westermann D; Zeller T; Karakas M
Clin Res Cardiol; 2019 Dec; 108(12):1386-1393. PubMed ID: 30989318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]